Pharming Group NV (PHGUF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 68,216 | 44,869 | 24,767 | -12,770 | N/A |
| Depreciation Amortization | 5,798 | 7,746 | 3,860 | 837 | N/A |
| Accounts receivable | -9,511 | -7,740 | -3,781 | -5,196 | N/A |
| Accounts payable and accrued liabilities | 9,718 | 1,643 | 16,770 | 7,800 | N/A |
| Other Working Capital | 3,642 | -4,894 | 12,545 | 710 | N/A |
| Other Operating Activity | -3,320 | 6,061 | -10,970 | -2,452 | -18,235 |
| Operating Cash Flow | $74,544 | $47,684 | $43,192 | $-11,070 | $-18,235 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,645 | -2,948 | -3,671 | -1,675 | -997 |
| Net Acquisitions | -20,946 | N/A | N/A | -61,925 | N/A |
| Purchase Of Investment | -2,803 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,848 | -1,503 | -3,161 | N/A | N/A |
| Other Investing Activity | -1,848 | -1,503 | -3,162 | 0 | 0 |
| Investing Cash Flow | $-28,243 | $-4,451 | $-6,833 | $-63,601 | $-997 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 103,234 | -5,410 | 17,238 |
| Debt Issued | N/A | N/A | N/A | 75,829 | N/A |
| Debt Repayment | -9,428 | -15,731 | -13,350 | N/A | N/A |
| Common Stock Issued | 3,111 | 12,396 | 7,723 | 9,766 | 536 |
| Other Financing Activity | -55,996 | -17,877 | -101,286 | -5,680 | -1,827 |
| Financing Cash Flow | $-62,312 | $-21,212 | $-3,679 | $74,504 | $15,948 |
| Exchange Rate Effect | 1,510 | 3,397 | -1,195 | 492 | 462 |
| Beginning Cash Position | 91,297 | 70,852 | 36,325 | 35,238 | 38,181 |
| End Cash Position | 76,795 | 96,269 | 67,810 | 35,563 | 35,359 |
| Net Cash Flow | $-14,502 | $25,418 | $31,486 | $325 | $-2,823 |
| Free Cash Flow | |||||
| Operating Cash Flow | 74,544 | 47,684 | 43,192 | -11,070 | -18,235 |
| Capital Expenditure | -2,645 | -2,948 | -3,671 | -1,320 | -997 |
| Free Cash Flow | 71,898 | 44,736 | 39,521 | -12,391 | -19,232 |